| Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ... The Lancet 390 (10106), 1949-1961, 2017 | 1678 | 2017 |
| Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial S Pignata, G Scambia, G Ferrandina, A Savarese, R Sorio, E Breda, ... Journal of clinical oncology 29 (27), 3628-3635, 2011 | 265 | 2011 |
| Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase … S Pignata, D Lorusso, G Scambia, D Sambataro, S Tamberi, S Cinieri, ... The Lancet Oncology 16 (5), 561-568, 2015 | 175 | 2015 |
| Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer A Passardi, E Scarpi, L Cavanna, M Dall'Agata, D Tassinari, S Leo, ... Oncotarget 7 (22), 33210, 2016 | 169 | 2016 |
| Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer L Crinò, G Bronte, P Bidoli, P Cravero, E Minenza, E Cortesi, ... Lung cancer 129, 35-40, 2019 | 152 | 2019 |
| Delayed emesis: incidence, pattern, prognostic factors and optimal treatment F Roila, D Donati, S Tamberi, G Margutti Supportive care in cancer 10 (2), 88-95, 2002 | 141 | 2002 |
| Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label … C Antoniotti, D Rossini, F Pietrantonio, A Catteau, L Salvatore, S Lonardi, ... The Lancet Oncology 23 (7), 876-887, 2022 | 129 | 2022 |
| Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer F Piscaglia, F Corradi, M Mancini, F Giangregorio, S Tamberi, G Ugolini, ... BMC cancer 7, 1-10, 2007 | 120 | 2007 |
| Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer E Bajetta, I Floriani, M Di Bartolomeo, R Labianca, A Falcone, ... Annals of oncology 25 (7), 1373-1378, 2014 | 109 | 2014 |
| Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon S Petta, G Cabibbo, M Barbara, S Attardo, L Bucci, F Farinati, EG Giannini, ... Alimentary pharmacology & therapeutics 45 (1), 160-168, 2017 | 95 | 2017 |
| Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial S De Placido, C Gallo, M De Laurentiis, G Bisagni, G Arpino, MG Sarobba, ... The Lancet Oncology 19 (4), 474-485, 2018 | 92 | 2018 |
| A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma G Cabibbo, S Petta, M Barbàra, G Missale, R Virdone, E Caturelli, ... Liver International 37 (8), 1157-1166, 2017 | 89 | 2017 |
| EGFR and K-ras Mutations Along the Spectrum of Pulmonary Epithelial Tumors of the Lung and Elaboration of a Combined Clinicopathologic and Molecular … G Sartori, A Cavazza, A Sgambato, A Marchioni, F Barbieri, L Longo, ... American journal of clinical pathology 131 (4), 478-489, 2009 | 84 | 2009 |
| The evolutionary scenario of hepatocellular carcinoma in Italy: an update L Bucci, F Garuti, B Lenzi, A Pecorelli, F Farinati, EG Giannini, A Granito, ... Liver International 37 (2), 259-270, 2017 | 82 | 2017 |
| Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib A Casadei Gardini, G Marisi, E Scarpi, M Scartozzi, L Faloppi, N Silvestris, ... Expert opinion on pharmacotherapy 16 (18), 2719-2725, 2015 | 74 | 2015 |
| Recurrent granulosa cell tumors (GCTs) of the ovary: a MITO-9 retrospective study G Mangili, C Sigismondi, L Frigerio, M Candiani, A Savarese, G Giorda, ... Gynecologic Oncology 130 (1), 38-42, 2013 | 74 | 2013 |
| Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC) F Cappuzzo, S Bartolini, GL Ceresoli, S Tamberi, A Spreafico, ... British journal of cancer 90 (1), 82-86, 2004 | 74 | 2004 |
| Comparison between alcohol‐and hepatitis C virus‐related hepatocellular carcinoma: clinical presentation, treatment and outcome L Bucci, F Garuti, V Camelli, B Lenzi, F Farinati, EG Giannini, F Ciccarese, ... Alimentary pharmacology & therapeutics 43 (3), 385-399, 2016 | 73 | 2016 |
| KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC) A Casadei Gardini, L Capelli, P Ulivi, M Giannini, E Freier, S Tamberi, ... PLoS One 9 (3), e92071, 2014 | 68 | 2014 |
| Kit expression in small cell carcinomas of the lung: effects of chemotherapy G Rossi, A Cavazza, A Marchioni, M Migaldi, M Bavieri, N Facciolongo, ... Modern pathology 16 (10), 1041-1047, 2003 | 65 | 2003 |
